Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)

Historic FCF Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 39713.15%.

  • ENDRA Life Sciences' FCF Margin changed N/A to 39713.15% in Q1 2018 from the same period last year, while for Dec 2018 it was 126376.43%, marking a year-over-year decrease of 1254376700.0%. This contributed to the annual value of 6836.54% for FY2024, which is 47555400.0% down from last year.
  • As of Q1 2018, ENDRA Life Sciences' FCF Margin stood at 39713.15%.
  • ENDRA Life Sciences' 5-year FCF Margin high stood at 304.81% for Q2 2016, and its period low was 39713.15% during Q1 2018.
  • Moreover, its 3-year median value for FCF Margin was 1083.98% (2017), whereas its average is 10293.96%.
  • Examining YoY changes over the last 5 years, ENDRA Life Sciences' FCF Margin showed a top increase of -22823200bps in 2017 and a maximum decrease of -199755900bps in 2017.
  • Over the past 3 years, ENDRA Life Sciences' FCF Margin (Quarter) stood at 105.93% in 2016, then plummeted by -18857bps to 20081.52% in 2017, then plummeted by -98bps to 39713.15% in 2018.
  • Its FCF Margin was 39713.15% in Q1 2018, compared to 20081.52% in Q4 2017 and 190.46% in Q3 2017.